Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Akoya Biosciences Inc.

    NASDAQ: AKYA · Real-Time Price · USD
    1.24
    -0.02 (-1.59%)
    At close: Jun 13, 2025, 3:59 PM
    1.27
    2.42%
    After-hours: Jun 13, 2025, 05:44 PM EDT

    Akoya Biosciences Statistics

    Share Statistics

    Akoya Biosciences has 49.88M shares outstanding. The number of shares has increased by 0.87% in one year.

    Shares Outstanding

    n/a
    		 49.88M

    Shares Change (YoY)

    n/a
    		 0.87%

    Shares Change (QoQ)

    n/a
    		 0.51%

    Owned by Institutions (%)

    n/a
    		 24.51%

    Shares Floating

    n/a
    		 20.81M

    Failed to Deliver (FTD) Shares

    n/a
    		 5,137

    FTD / Avg. Volume

    n/a
    		 1.09%

    Short Selling Information

    The latest short interest is 2.84M, so 5.7% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 2.84M

    Short % of Shares Out

    n/a
    		 5.7%

    Short % of Float

    n/a
    		 8.95%

    Short Ratio (days to cover)

    n/a
    		 1.45

    Valuation Ratios

    The PE ratio is -2.04 and the forward PE ratio is -2. Akoya Biosciences's PEG ratio is 0.09.

    PE Ratio

    n/a
    		 -2.04

    Forward PE

    n/a
    		 -2

    PS Ratio

    n/a
    		 1.39

    Forward PS

    n/a
    		 0.5

    PB Ratio

    n/a
    		 14.9

    P/FCF Ratio

    n/a
    		 -2.43

    PEG Ratio

    n/a
    		 0.09
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Akoya Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.61, with a Debt / Equity ratio of 11.08.

    Current Ratio

    n/a
    		 2.61

    Quick Ratio

    n/a
    		 1.78

    Debt / Equity

    n/a
    		 11.08

    Debt / EBITDA

    n/a
    		 -2.27

    Debt / FCF

    n/a
    		 -1.81

    Interest Coverage

    n/a
    		 -4.48

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $398,400

    Profits Per Employee

    n/a
    		 $-270,073.17

    Employee Count

    n/a
    		 205

    Asset Turnover

    n/a
    		 0.65

    Inventory Turnover

    n/a
    		 1.39

    Taxes

    Income Tax

    n/a
    		 146K

    Effective Tax Rate

    n/a
    		 -0.26%

    Stock Price Statistics

    The stock price has increased by -43.89% in the last 52 weeks. The beta is 1.35, so Akoya Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.35

    52-Week Price Change

    n/a
    		 -43.89%

    50-Day Moving Average

    n/a
    		 1.18

    200-Day Moving Average

    n/a
    		 2.13

    Relative Strength Index (RSI)

    n/a
    		 51.41

    Average Volume (20 Days)

    n/a
    		 472,852

    Income Statement

    In the last 12 months, Akoya Biosciences had revenue of 81.67M and earned -55.37M in profits. Earnings per share was -1.12.

    Revenue

    n/a
    		 81.67M

    Gross Profit

    n/a
    		 47.88M

    Operating Income

    n/a
    		 -46.73M

    Net Income

    n/a
    		 -55.37M

    EBITDA

    n/a
    		 -37.14M

    EBIT

    n/a
    		 -44.79M

    Earnings Per Share (EPS)

    n/a
    		 -1.12
    Full Income Statement

    Balance Sheet

    The company has 11.78M in cash and 84.15M in debt, giving a net cash position of -72.37M.

    Cash & Cash Equivalents

    n/a
    		 11.78M

    Total Debt

    n/a
    		 84.15M

    Net Cash

    n/a
    		 -72.37M

    Retained Earnings

    n/a
    		 -285.44M

    Total Assets

    n/a
    		 112.65M

    Working Capital

    n/a
    		 -41.87M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -44.1M and capital expenditures -2.46M, giving a free cash flow of -46.56M.

    Operating Cash Flow

    n/a
    		 -44.1M

    Capital Expenditures

    n/a
    		 -2.46M

    Free Cash Flow

    n/a
    		 -46.56M

    FCF Per Share

    n/a
    		 -0.94
    Full Cash Flow Statement

    Margins

    Gross margin is 58.62%, with operating and profit margins of -57.22% and -67.79%.

    Gross Margin

    n/a
    		 58.62%

    Operating Margin

    n/a
    		 -57.22%

    Pretax Margin

    n/a
    		 -67.61%

    Profit Margin

    n/a
    		 -67.79%

    EBITDA Margin

    n/a
    		 -45.47%

    EBIT Margin

    n/a
    		 -57.22%

    FCF Margin

    n/a
    		 -57.01%

    Dividends & Yields

    AKYA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for AKYA is $1.8, which is 45.2% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $1.8

    Price Target Difference

    n/a
    		 45.2%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -4.27

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist